Source: Base de données publique des médicaments (FR) Revision Year: 2011 Publisher: Bayer Vital GmbH, D-51368 Leverkusen Tel.: (02 14) 30 – 51348 Fax: (02 14) 30 – 51603 Email address: bayer-vital@bayerhealthcare.com
Irenat Drops.
300 mg sodium perchlorate, oral drops.
Sodium perchlorate monohydrate.
| Pharmaceutical Form |
|---|
|
Oral drops. |
1 ml solution (approximately 15 drops) contains 344.2 mg sodium perchlorate monohydrate (equivalent to 300 mg sodium perchlorate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Sodium perchlorate |
Perchlorate competitively inhibits the thyroid’s iodine uptake mechanism, iodination and affects iodisation by flushing the thyroid of iodide that is accumulating but has not yet been incorporated into a thyroglobulin molecule. Re-utilisation of iodide released outside the thyroid during deiodination of thyroid hormone is also inhibited. The antithyroid effect is based on the occurrence of iodine depletion. |
| List of Excipients |
|---|
|
Ammonium chloride |
Irenat drops are available in a vial containing 40 ml solution.
Bayer Vital GmbH, D-51368 Leverkusen
Tel.: (02 14) 30 – 51348
Fax: (02 14) 30 – 51603
Email address: bayer-vital@bayerhealthcare.com
6044463.00.00
Date of first authorisation: 09.10.1996
Date of latest renewal: 22.11.2001
| Drug | Countries | |
|---|---|---|
| IRENAT | Estonia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
